IP Library Granted Patent US 8,157,760
Granted Patent B2
US 8,157,760 · App. 12/176,250 · Granted Apr 17, 2012

Methods and systems for establishing retrograde carotid arterial blood flow

Assignee: Silk Road Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,157,760
App. No.
12/176,250
Granted
Apr 17, 2012
Kind
B2
Abstract

Interventional procedures on the carotid arteries are performed through a transcervical access while retrograde blood flow is established from the internal carotid artery to a venous or external location. A system for use in accessing and treating a carotid artery includes an arterial access device, a shunt fluidly connected to the arterial access device, and a flow control assembly coupled to the shunt and adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state. The flow control assembly includes one or more components that interact with the blood flow through the shunt.

Claims (52)

1. A method for accessing and treating a carotid artery, comprising:

forming a transcervical incision in a neck of a patient;

forming a penetration in a wall of a common carotid artery via the transcervical incision, the penetration being located at distance of around 5 cm to 7 cm below a bifurcation location where the patient's common carotid artery bifurcates into an internal carotid artery and external carotid artery;

positioning an arterial access sheath through the transcervical incision and the penetration, wherein the arterial access sheath has a working length of 5 cm to 15 cm;

inserting no more than the working length of the arterial access sheath into the common carotid artery;

blocking blood flow from the common carotid artery past the sheath;

allowing retrograde blood flow from the internal carotid artery into the sheath and into a shunt from the sheath while the common carotid artery remains blocked; and

adjusting the state of retrograde blood flow through the shunt.

2. A method as in claim 1 , wherein adjusting the state of retrograde blood flow comprises changing from a passive flow state to an active flow state.

3. A method as in claim 1 , wherein adjusting the state of retrograde blood flow comprises changing the flow rate from a passive low flow state to a passive high flow state.

4. A method as in claim 3 , wherein the rate is controlled over a range from a low rate to a high rate, where the high rate is at least three fold higher than the low rate.

5. A method as in claim 3 , wherein the high rate is at least three fold higher than the low rate.

6. A method as in claim 3 , wherein the high rate is at least five fold higher than the low rate.

7. A method as in claim 1 , wherein adjusting the state of retrograde blood flow comprises changing the flow rate from a passive low flow state to an active high flow state.

8. A method as in claim 1 , wherein adjusting the state of retrograde blood flow comprises changing the flow rate from a passive low flow state to a state where blood flow through the shunt is aspirated.

9. A method as in claim 1 , wherein adjusting comprises adjusting flow resistance from the arterial access sheath to a return site, wherein the flow resistance within the shunt is adjusted using a flow control element attached directly to the shunt.

10. A method as in claim 9 , wherein the resistance is adjusted causing blood to flow through a flow resistance element coupled to the shunt.

11. A method as in claim 1 , wherein adjusting comprises actively pumping blood from the arterial access sheath to a venous return site.

12. A method as in claim 1 , wherein retrograde flow is controlled at a baseline low flow rate in the range from 10 ml/min to 200 ml/min during a majority of a procedure.

13. A method as in claim 1 , wherein the retrograde flow is increased to a higher rate when there is an increased risk of emboli release.

14. A method as in claim 1 , wherein the procedure comprises stenting of the internal carotid artery and the flow rate is increased during at least one of when a stent delivery catheter is introduced to the carotid artery, when the stent is deployed in the carotid artery, when the stent delivery catheter is removed from the carotid artery, or when the common carotid artery occlusion is released.

15. A method as in claim 1 , wherein the flow rate is increased manually by the user.

16. A method as in claim 1 , wherein the flow rate is increased automatically.

17. A method as in claim 1 , further comprising measuring the retrograde flow rate, wherein the continuous retrograde flow rate is controlled based on the measured flow rate.

18. A method as in claim 1 , wherein the rate of retrograde flow is cycled between a lower flow rate and a higher flow rate to dislodge emboli from the common and external carotid arteries.

19. A method for accessing and treating a carotid artery, comprising:

forming a penetration in a wall of a common carotid artery;

positioning an arterial access sheath through the penetration;

blocking blood flow from the common carotid artery past the sheath;

allowing retrograde blood flow from the internal carotid artery into the sheath and into a shunt from the sheath while the common carotid artery remains blocked; and

adjusting the state of retrograde blood flow through the shunt, wherein adjusting comprises adjusting flow resistance from the arterial access sheath to a return site by causing blood to flow through a flow resistance element coupled to the shunt, wherein the flow resistance element comprises two or more parallel flow paths of the shunt and a valve to open or close one or more of the flow paths to selectively direct blood flow through one or more of the flow paths.

20. A method as in claim 19 , wherein the parallel flow paths include a main flow path and a secondary flow path, and wherein the secondary flow path has a higher resistance to blood flow than the main flow path.

21. A method as in claim 20 , wherein the secondary flow path is longer than the main flow path.

22. A method as in claim 20 , wherein the secondary flow path has a smaller diameter than the main flow path.

23. A method as in claim 20 , wherein the valve is configured to block blood flow through the main flow path of the shunt such that blood flow through the shunt is diverted entirely to the secondary flow path thereby increasing the flow resistance and reducing the blood flow rate through the shunt.

24. A method as in claim 19 , further comprising a controller that can be actuated by a user to control the valve.

25. A method as in claim 24 , wherein the flow resistance element and the controller are integrated into a single housing.

26. A method as in claim 19 , wherein retrograde flow is controlled at a baseline low flow rate in the range from 10 ml/min to 200 ml/min during a majority of a procedure.

27. A method as in claim 19 , wherein the retrograde flow is increased to a higher rate when there is an increased risk of emboli release.

28. A method as in claim 19 , wherein the procedure comprises stenting of the internal carotid artery and the flow rate is increased during at least one of when a stent delivery catheter is introduced to the carotid artery, when the stent is deployed in the carotid artery, when the stent delivery catheter is removed from the carotid artery, or when the common carotid artery occlusion is released.

29. A method as in claim 19 , wherein the flow rate is increased manually by the user.

30. A method as in claim 19 , wherein the flow rate is increased automatically.

31. A method as in claim 19 , further comprising measuring the retrograde flow rate, wherein the continuous retrograde flow rate is controlled based on the measured flow rate.

32. A method as in claim 19 , wherein the rate of retrograde flow is cycled between a lower flow rate and a higher flow rate to dislodge emboli from the common and external carotid arteries.

33. A method for accessing and treating a carotid artery, comprising:

forming a transcervical incision in a neck of a patient;

forming a penetration in a wall of a common carotid artery;

inserting a distal section of the arterial access sheath through the transcervical incision and the penetration, wherein the arterial access sheath includes a removable stopper member that covers a portion of the distal section of the sheath such that a portion of the distal section of the sheath is covered by the stopper member and a portion of the distal section of the sheath is exposed, wherein the stopper member, when coupled to the sheath, limits insertion of the sheath into the carotid artery to the exposed portion;

inserting no more than the exposed portion of the sheath into the common carotid artery;

blocking blood flow from the common carotid artery past the sheath;

allowing retrograde blood flow from the internal carotid artery into the sheath and into a shunt from the sheath while the common carotid artery remains blocked; and

adjusting the state of retrograde blood flow through the shunt using a flow control element attached directly to the shunt.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2025
From: SILK ROAD MEDICAL, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 070671/0426 →
RELEASE OF SECURITY INTEREST Recorded Sep 17, 2024
From: OXFORD FINANCE, LLC
To: SILK ROAD MEDICAL, INC.
Reel/Frame 068979/0196 →
SECURITY INTEREST Recorded Jul 11, 2023
From: SILK ROAD MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 064252/0197 →
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2020
From: CRG PARTNERS III L.P.; CRG PARTNERS III - PARALLEL FUND "A" L.P.; CRG PARTNERS III - PARALLEL FUND "B" (CAYMAN) L.P.; CRG PARTNERS III (CAYMAN) L.P.
To: SILK ROAD MEDICAL, INC.
Reel/Frame 054225/0451 →
SECURITY INTEREST Recorded Oct 13, 2015
From: SILK ROAD MEDICAL, INC.
To: CRG PARTNERS III L.P.; CRG PARTNERS III - PARALLEL FUND "A" L.P.; CRG PARTNERS III - PARALLEL FUND "B" (CAYMAN) L.P.; CRG PARTNERS III (CAYMAN) L.P.
Reel/Frame 036852/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2008
From: CRIADO, ENRIQUE; CHOU, TONY M.; GARRISON, MICHI E.; HYDE, GREGORY M.; SCHAER, ALAN; RENATI, RICHARD
To: SILK ROAD MEDICAL, INC.
Reel/Frame 021615/0179 →
Continuity (3)
Provisional Application 60950384 · Jul 18, 2007
Provisional Application 61026308 · Feb 5, 2008
Related Publication 20090024072A1 · Jan 22, 2009